Patent Assignment
Reel/Frame 041735/0671
Change of Name
Recorded: 2017-02-16
Pages: 4
Assignor
BIOGEN HEMOPHILIA INC.
Executed: 2016-09-01
Assignee
BIOVERATIV THERAPEUTICS INC.
225 SECOND AVENUE, WALTHAM, MASSACHUSETTS, 02451
Covered Properties
(4)
PC5 as a Factor Ix Propeptide Processing Enzyme
PC5 as a Factor Ix Propeptide Processing Enzyme
PC5 as a Factor Ix Propeptide Processing Enzyme
PC5 as a factor IX propeptide processing enzyme
Application:
60/785,421 →
Related Assignments
(9)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest
Nov 9, 2006
From: PETERS, ROBERT T.; BITONTI, ALAN J.
To: SYNTONIX PHARMACEUTICALS, INC.
Reel/Frame 018501/0185 →
Security Agreement
Jan 12, 2007
From: SYNTONIX PHARMACEUTICALS, INC.
To: BIOGEN IDEC INC.
Reel/Frame 018764/0586 →
Release & Reassignment
Mar 5, 2007
From: BIOGEN IDEC INC.
To: SYNTONIX PHARMACEUTICALS, INC.
Reel/Frame 018964/0431 →
Assignment of Assignor's Interest
Apr 20, 2007
From: PETERS, ROBERT T.; BITONTI, ALAN J.
To: SYNTONIX PHARMACEUTICALS, INC.
Reel/Frame 019188/0413 →
Corrective Assignment to Correct the State of Incorporation of Assignee Previously Recorded on Reel 019188 Frame 0413. Assignor(S) Hereby Confirms the Assignment of Us Serial No. 11/728045.
Jun 8, 2007
From: PETERS, ROBERT T.; BITONTI, ALAN J.
To: SYNTONIX PHARMACEUTICALS, INC.
Reel/Frame 019398/0693 →
Assignment of Assignor's Interest
Nov 16, 2009
From: PETERS, ROBERT T.; BITONTI, ALAN J.
To: SYNTONIX PHARMACEUTICALS, INC.
Reel/Frame 023522/0317 →
Assignment of Assignor's Interest
Jan 24, 2011
From: PETERS, ROBERT T.; BITONTI, ALAN J.
To: SYNTONIX PHARMACEUTICALS, INC.
Reel/Frame 025683/0115 →
Change of Name
Jun 29, 2016
From: SYNTONIX PHARMACEUTICALS, INC.
To: BIOGEN IDEC HEMOPHILIA INC.
Reel/Frame 039206/0091 →
Change of Name
Jan 31, 2017
From: BIOGEN IDEC HEMOPHILIA INC.
To: BIOGEN HEMOPHILIA INC.
Reel/Frame 041578/0743 →